Phase 3 Study of SK-1403

NCT03801980 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

153

Enrollment

INDUSTRY

Sponsor class

Conditions

Secondary Hyperparathyroidism

Interventions

DRUG: SK-1403
DRUG: Placebo

Sponsor

Sanwa Kagaku Kenkyusho Co., Ltd.